Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

DXS International plc Ordinary 0.33p

Sell:6.00p Buy:7.00p Change: No change
Market closed |  Prices as at close on 24 June 2020 | Switch to live prices |
Change: No change
Market closed |  Prices as at close on 24 June 2020 | Switch to live prices |
Change: No change
Market closed |  Prices as at close on 24 June 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

DXS International PLC is engaged in the development and distribution of clinical decision support to general practitioners, nurses and retail pharmacies in the United Kingdom and South Africa. The Company is also engaged in licensing its services to various clinical commissioning groups (CCGs); selling of e-detailing opportunities to the pharmaceutical industry and the United Kingdom care sector, and licensing of DXS technology to healthcare publishers. The Company's products include DXS Point-of-Care (DXS PoC), which is a clinical decision support system (CDSS); DXS Best Pathway, which supports the implementation of CCG designated clinical guidelines and protocols; DXS Best Script, which is a medicine database; DXS Best Triage, which manages CCG referral triaging requirements, and DXS Directory-of-Services (DoS), which provides general practitioners (GPs) and nurses with a directory of available referral services in the work flow.

Contact details

Wrecclesham House, Wrecclesham Road
GU10 4PS
United Kingdom
+44 (01252) 719800

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Market cap:
£3.14 million
Shares in issue:
35.58 million
No specific industry
Sterling pence

Key personnel

  • David Immelman
    Chief Executive Officer, Director
  • Steven Bauer
    Director of Sales, Director
  • David Papworth
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.